This study evaluated the prevalence and management of incidental hepatic steatosis found on ultrasounds of patients who underwent elective cholecystectomy. The study highlighted that steatosis has not received proper medical attention, with little documentation, research or advice on lifestyle changes.
Tag: metabolic dysfunction-associated steatotic liver disease
Renal injury and metabolic dysfunction-associated steatotic liver disease in patients with obesity
Clinical investigation between kidney injury and Metabolic Dysfunction-Associated Fatty Liver Disease (MASLD) in patients with obesity grades II and III. The results suggest that while age is a primary determinant of GFR decline, progression of liver fibrosis may also be a significant contributing factor to renal function impairment, and glomerular hyperfiltration may be an early sign of progression to chronic kidney disease.
Association between anxiety and depression in metabolic dysfunction-associated steatotic liver disease (MASLD)
The impression that anxiety or depression may be associated with hepatic steatosis is not confirmed in this study.


